Chan Ye Xin Xi Wang·2025-12-05 01:26Core Insights - The pharmaceutical-grade fish oil market is experiencing significant growth due to its high purity levels of EPA and DHA, which are crucial for cardiovascular disease prevention and brain health maintenance [1][3][4] - The global demand for pharmaceutical-grade fish oil is projected to increase, with sales expected to reach 31,400 tons in 2024, an increase of 5.9% from 2023 [3][4] - In China, the pharmaceutical-grade fish oil market is also expanding, with sales anticipated to reach 5,500 tons in 2024, reflecting a growth of 25% from the previous year [4] Industry Definition and Characteristics - Pharmaceutical-grade fish oil is derived from fatty fish and is characterized by its high concentration of omega-3 fatty acids, specifically EPA and DHA, which are validated for specific medical purposes [2][3] - Unlike regular dietary supplements, pharmaceutical-grade fish oil is a prescription-level treatment product with strong clinical evidence supporting its efficacy [2] Current Industry Status - The pharmaceutical-grade fish oil industry is witnessing a surge in demand driven by increasing health awareness among consumers, an aging population, and rising chronic disease rates [3][4] - The market is expected to see a steady increase in sales, with global sales projected to reach approximately 31,600 tons by 2025 [3] Industry Chain - The industry chain consists of upstream raw materials such as herring, mackerel, sardines, and tuna, which are processed into crude fish oil [5] - The midstream involves the production of pharmaceutical-grade fish oil, which has the highest technical barriers [5] - Downstream applications include pharmaceuticals, clinical nutrition, and high-end dietary supplements [5] Development Environment and Policies - The pharmaceutical-grade fish oil industry in China is supported by national policies aimed at promoting and regulating the sector, including standards for food safety and specific regulations for omega-3 fish oil products [6][7] Competitive Landscape - The Chinese pharmaceutical-grade fish oil market is characterized by competition among international pharmaceutical giants, leading domestic raw material and manufacturing companies, and health supplement brands [7][9] - The market is consolidating as stricter regulations and higher technical barriers drive competition towards leading players [7] Development Trends - The industry is moving towards a new phase characterized by high quality, strong evidence, precision, and globalization, with trends indicating a shift towards more precise, diversified, and evidence-based applications [11]